The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Avdeev S.N.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Gaynitdinova V.V.

I.M. Sechenov First Moscow State Medical University

Pozdnyakova A.A.

University Clinical Hospital No. 4 of the I.M. Sechenov First Moscow State Medical University

Gneusheva T.Yu.

I.M. Sechenov First Moscow State Medical University

Vlasenko A.E.

Novokuznetskiy State Institute for Advanced Training of Doctors — Branch of Russian Medical Academy of Continuous Professional Education

Baitimerova I.V.

Ufa City Clinical Hospital No. 5

Samsonova M.D.

Sechenov First Moscow State Medical University (Sechenov University)

Asthma in the elderly and COVID-19: results of the 90-day post-hospital follow-up

Authors:

Avdeev S.N., Gaynitdinova V.V., Pozdnyakova A.A., Gneusheva T.Yu., Vlasenko A.E., Baitimerova I.V., Samsonova M.D.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2023;26(3): 91‑100

Read: 996 times


To cite this article:

Avdeev SN, Gaynitdinova VV, Pozdnyakova AA, Gneusheva TYu, Vlasenko AE, Baitimerova IV, Samsonova MD. Asthma in the elderly and COVID-19: results of the 90-day post-hospital follow-up. Russian Journal of Preventive Medicine. 2023;26(3):91‑100. (In Russ.)
https://doi.org/10.17116/profmed20232603191

Recommended articles:
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146
Diffuse changes in the brain in the acute phase of COVID-19 and after infe­ction. Russian Journal of Archive of Pathology. 2025;(1):5-15
Liver pathology in COVID-19. Russian Journal of Archive of Pathology. 2025;(1):53-59

References:

  1. Leung K, Wu JT, Liu D, Leung GM. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment. Lancet. 2020; 395(10233):1382-1393. https://doi.org/10.1016/S0140-6736(20)30746-7
  2. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, Luo J, Huang Z, Tu S, Zhao Y, Chen L, Xu D, Li Y, Li C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan G, Xu J, Wang G, Wang Y, Zhong J, Wang C, Wang J, Zhang D, Cao B. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270): 220-232.  https://doi.org/10.1016/S0140-6736(20)32656-8
  3. Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E, Corre F, Zarrouk V, Moyer JD, Galy A, Honsel V, Fantin B, Nguyen Y. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):4-6.  https://doi.org/10.1016/j.jinf.2020.08.029
  4. Goërtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, Houben-Wilke S, Burtin C, Posthuma R, Franssen FME, van Loon N, Hajian B, Spies Y, Vijlbrief H, van ‘t Hul AJ, Janssen DJA, Spruit MA. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542-02020. https://doi.org/10.1183/23120541.00542-2020
  5. Rosales-Castillo A, García de Los Ríos C, Mediavilla García JD. Persistent symptoms after acute COVID-19 infection: importance of follow-up. Med Clin (Barc). 2021;156:35-36.  https://doi.org/10.1016/j.medcli.2020.08.001
  6. Carfì A, Bernabei R, Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-605.  https://doi.org/10.1001/jama.2020.12603
  7. Günster C, Busse R, Spoden M, Rombey T, Schillinger G, Hoffmann W, Weber-Carstens S, Schuppert A, Karagiannidis C. 6-month mortality and readmissions of hospitalized COVID-19 patients: A nationwide cohort study of 8,679 patients in Germany. PLoS One. 2021;16(8):e0255427. https://doi.org/10.1371/journal.pone.0255427
  8. Romero-Duarte Á, Rivera-Izquierdo M, Guerrero-Fernández de Alba I, Pérez-Contreras M, Fernández-Martínez NF, Ruiz-Montero R, Serrano-Ortiz Á, González-Serna RO, Salcedo-Leal I, Jiménez-Mejías E, Cárdenas-Cruz A. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. 2021;19(1):129.  https://doi.org/10.1186/s12916-021-02003-7
  9. Biancari F, Mariscalco G, Dalén M, Settembre N, Welp H, Perrotti A, Wiebe K, Leo E, Loforte A, Chocron S, Pacini D, Juvonen T, Broman LM, Perna DD, Yusuff H, Harvey C, Mongardon N, Maureira JP, Levy B, Falk L, Ruggieri VG, Zipfel S, Folliguet T, Fiore A. Six-Month Survival After Extracorporeal Membrane Oxygenation for Severe COVID-19. J Cardiothorac Vasc Anesth. 2021;35(7):1999-2006. https://doi.org/10.1371/journal.pone.0255427
  10. Aveyard P, Gao M, Lindson N, Hartmann-Boyce J, Watkinson P, Young D, Coupland CAC, Tan PS, Clift AK, Harrison D, Gould DW, Pavord ID, Hippisley-Cox J. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. The Lancet Respiratory Medicine. 2021;9(8):909-923.  https://doi.org/10.1080/02770903.2020.1857396
  11. Ritchie AI, Jackson DJ, Edwards MR, Johnston SL. Airway epithelial orchestration of innate immune function in response to virus infection. A focus on asthma. Ann Am Thorac Soc. 2016;13(suppl 1):55-63.  https://doi.org/10.1513/AnnalsATS.201507-421MG
  12. Scichilone N, Pedone C, Battaglia S, Sorino C, Bellia V. Diagnosis and management of asthma in the elderly. European Journal of Internal Medicine. 2014;25(4):336-342.  https://doi.org/10.1016/j.ejim.2014.01.004
  13. Battaglia S, Benfante A, Spatafora M, Scichilone N. Asthma in the elderly: a different disease? Breathe. 2016;12(1):18-28.  https://doi.org/10.1183/20734735.002816
  14. Avdeev SN, Pozdnakova AA, Gaynitdinova VV, Chikina SYu, Vlasenko AE. Asthma in older adults with severe COVID-19: clinical outcomes and predictors of mortality. Annals of Allergy, Asthma Immunology. 2022;128(2): 213-215.  https://doi.org/10.1016/j.anai.2021.10.016
  15. Gaynitdinova VV, Avdeev NN, Pozdniakova AA, Vlasenko AY, Baytimerova IV, Gneusheva TV. Asthma and COVID-19 in the elderly: course, survival, predictors of mortality. Pulmonologiya. 2022;32(2):151-161. (In Russ.). https://doi.org/10.18093/0869-0189-2022-32-2-151-161
  16. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2020. Website. Accessed March 1, 2023. https://www.ginasthma.org
  17. Fernando SM, McIsaac DI, Rochwerg B, Bagshaw SM, Muscedere J, Munshi L, Ferguson ND, Seely AJE, Cook DJ, Dave C, Tanuseputro P, Kyeremanteng K. Frailty and invasive mechanical ventilation: association with outcomes, extubation failure, and tracheostomy. Intensive Care Med. 2019; 45(12):1742-1752. https://doi.org/10.1007/s00134-019-05795-8
  18. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ, Li L, Chen PY, Sang L, Wang W, Li JF, Li CC, Ou LM, Cheng B, Xiong S, Ni ZY, Xiang J, Hu Y, Liu L, Shan H, Lei CL, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Cheng LL, Ye F, Li SY, Zheng JP, Zhang NF, Zhong NS, He JX; China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5): 2000547. https://doi.org/10.1183/13993003.00547-2020
  19. Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry. 2021;8(5):416-427.  https://doi.org/10.1016/S2215-0366(21)00084-5
  20. Hewitt J, Carter B, Vilches-Moraga A, Quinn TJ, Braude P, Verduri A, Pearce L, Stechman M, Short R, Price A, Collins JT, Bruce E, Einarsson A, Rickard F, Mitchell E, Holloway M, Hesford J, Barlow-Pay F, Clini E, Myint PK, Moug SJ, McCarthy K; COPE Study Collaborators. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health. 2020;5(8):444-451.  https://doi.org/10.1016/S2468-2667(20)30146-8
  21. Garcia-Vidal C, Cózar-Llistó A, Meira F, Dueñas G, Puerta-Alcalde P, Cilloniz C, Garcia-Pouton N, Chumbita M, Cardozo C, Hernández M, Rico V, Bodro M, Morata L, Castro P, Almuedo-Riera A, García F, Mensa J, Antonio Martínez J, Sanjuan G, Torres A, Nicolás JM, Soriano A; COVID-19-researcher group. Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain. The Lancet Regional Health — Europe. 2021;3:100041. https://doi.org/10.1016/j.lanepe.2021.100041
  22. Brieghel C, Ellekvist P, Lund ML, Soborg C, Walsted ES, Thomsen JJ, Brieghel C, Ellekvist P, Lund ML, Søborg C, Walsted ES, Thomsen JJ, Biering-Sørensen T, Mohr T, Knop FK, Ravn P. Prognostic factors of 90-day mortality in patients hospitalised with COVID-19. Dan Med J. 2021;68(3): A09200705.
  23. Zettersten E, Engerström L, Bell M, Jäderling G, Mårtensson J, Block L, Larsson E. Long-term outcome after intensive care for COVID-19: differences between men and women-a nationwide cohort study. Crit Care. 2021; 25(1):86.  https://doi.org/10.2139/ssrn.3822280
  24. Choi YJ, Park JY, Lee HS, Suh J, Song JY, Byun MK, Cho JH, Kim HJ, Lee JH, Park JW, Park HJ. Effect of asthma and asthma medication on the prognosis of patients with COVID-19. Eur Respir J. 2021;57:2002226. https://doi.org/10.1183/13993003.02226-2020

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.